Financial Daily from THE HINDU group of publications
Tuesday, Aug 02, 2005


News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate Results - Bio-tech & Genetics


Sterling Biotech Q2 net up 53 pc

Our Bureau

Mumbai , Aug. 1

STERLING Biotech has posted a 53.6 per cent rise in the net profit of the second quarter ended June at Rs 26.64 crore (Rs 17.34 crore).

Total sales rose by 22.7 per cent to Rs 120 crore (Rs 97.8 crore), a note from the company said.

For the half-year ended June 2005, the company's total sales stood at Rs 230.23 crore and net profit of Rs 51.19 crore.

Mr Nitin Sandesara, Chairman, Sterling Biotech said: "The current quarter results reflect the benefits of cost and operational efficiencies. Sterling has more than seven per cent market share in pharma-gelatin globally and is well known for its product quality in developed countries. The expansion facility will further our position in the international market besides assuring a regular supply to our customers."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
FACT prunes net loss


HPCL in the red; Q1 loss at Rs 507.89 cr
Assam Company turnover, net up
Gulf Oil Q1 net up 12 pc
Dishman Pharma net rises 52 %
Suven Life Sciences net up
Birla Power Q1 net rise
Mawana Sugars net zooms
Upper Ganges net rises 64 %
Rajasthan Spinning posts higher net
D-Link Q1 net down 21 pc
HCL Peripherals sees Rs 360-cr revenue
Bhagyanagar Metals net dips
Sterling Biotech Q2 net up 53 pc
LIC Housing Q1 net up 20 pc at Rs 50 cr
Hind Sanitaryware net up 70 pc in first quarter
Kajaria Q1 net up 26 pc
Karnataka Bank Q1 net rises to Rs 42 cr
TCIL Q1 net profit, sales up


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line